LEU— AI Stock Forecast & Price Targets
Published 8/6/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live LEU price forecast →
Centrus retains a genuine structural moat as the sole U.S.-licensed HALEU enricher with a fresh $1B+ DOE contract, $1.87B cash, and a $3.9B+ backlog, but Q2'26 print (Aug 5 AMC) missed EPS while beating revenue, sending shares ~5.7% lower after-hours. At ~$187 with forward P/E ~68x, EV/EBITDA ~73x, negative TTM operating margin, and Q1'26 FCF burn of -$58M, valuation offers no cushion — the stock is caught between a legitimate long-term monopoly narrative and near-term margin/dilution overhang.
HOLD, do not add into the post-earnings gap. The EPS miss + JPM target cut + rejection at $192 sets up a likely retest of $172-176 (aligned with the 1H Forecast anchor). If shares hold $172 on the reaction, that's a base to reassess; a decisive break below $160 opens $148 and invalidates the near-term recovery. Do not chase back above $195 without a clean daily reclaim on volume — prior rallies into this zone have been rejected. Sizing: trim on a bounce back to $195-200 into strength; add only on a defended $160-165 flush with holder-friendly commentary on burn/dilution.
1-6 month view: range-bound between $155-215 is the most probable path. Base case ~$180 (roughly flat to -4%), bull case ~$220 (+17%) requires either (a) a clean beat + margin repeat in Q3'26 above 30% gross, or (b) a new customer/contract announcement rivaling the DOE deal. Bear case $145 (-23%) triggers on any equity raise announcement or a Q3'26 gross margin below 20%. Catalysts: Q3'26 print, DOE option exercise milestones, Oak Ridge capex pacing updates, any Oklo-linked commercial contract terms. Mind-changer: an unambiguous FCF-positive quarter with capex discipline OR, conversely, a >$300M capital raise.
1-3 year: The terminal thesis is intact — Centrus is the U.S. HALEU chokepoint at exactly the moment SMR/advanced-reactor deployment moves from concept to fuel orders, backed by $3.9B+ backlog through 2040. If Piketon reaches commercial cascade operation on schedule and margins normalize in the 25-30% range on a full-capacity revenue base of $700M-1B, the current $3.7B market cap is defensible. Biggest structural risk is capex overrun forcing dilutive equity raises at depressed prices, which would compound with any delay in advanced-reactor deployment (Oklo, NuScale still pre-revenue). Secondary risk: Urenco or a policy-favored new entrant erodes the exclusivity premium by 2028-2029.
Revenue trend is lumpy: Q2'25 $154.5M → Q3'25 $74.9M → Q4'25 $146.2M → Q1'26 $76.7M, and the just-reported Q2'26 came in at $176.1M (+14% YoY) — a beat on the top line but EPS of $0.77 missed consensus. Gross margins swing wildly (Q3'25 -5.7%, Q4'25 23.9%, Q1'26 41.1%), confirming the thesis that single-quarter margin prints are unreliable. TTM operating margin is negative (-0.26%) even as net margin sits at 13.4% (helped by non-operating income on the large cash pile). Balance sheet is a genuine strength: $1.87B cash, current ratio 5.72, quick ratio 4.79, working capital $1.89B — but total debt has ballooned to $1.18B (D/E 1.52) and stockholders' equity is only $775M. Cash flow quality is deteriorating fast: Q1'26 operating cash flow -$35.1M and FCF -$58.3M, with capex accelerating (-$23.2M in Q1'26 vs -$3.6M a year prior) as Piketon/Oak Ridge build-out ramps. The $560M Oak Ridge commitment and Piketon expansion mean the cash cushion, while large, has a measurable runway (~8 quarters at current burn) before capital raise pressure returns. Capital allocation is defensible strategically but painful for near-term FCF and dilution optics.
The 1D chart shows a powerful reclaim from the July $148 low to $192 highs — a ~30% rip in ~3 weeks — printing SMA20 +11.1% and SMA50 +9.7% while still -17.2% below SMA200, i.e. a countertrend rally into major overhead supply from the Jan-May $200-230 range. RSI 58.6 is elevated but not overbought. The 1H forecast band explicitly projects a fade from $192 down toward $174 (Forecast line), consistent with the after-hours -5.7% gap on the EPS miss. The 4H forecast is more constructive ($205 target above current), and the 1D forecast paints an aggressive rebound to $230+ — but realized directional accuracy at 1d (67%) is BELOW the 71% naive baseline and 1wk accuracy is 0%, so those upside bands must be discounted heavily. The 1WK chart is a reminder of the tape's history: shares peaked near $385 and have been in a lower-highs regime for 6+ months; $190-200 is the exact zone where prior rallies were rejected. Key levels: support $172-176 (Forecast anchor + prior consolidation), then $160, then $148 (52W-relevant low). Resistance: $195-200 (immediate), $220-230 (major), $260 (structural).
The signal news is the July 1 finalization of a $1B+ DOE HALEU contract (including options) plus early delivery of 900kg HALEU UF6 under the prior demo contract — this is real, materially de-risks the enrichment expansion narrative, and validates the sole-U.S.-licensee moat. Layer in the new Oklo partnership and the $560M Oak Ridge expansion and the multi-year growth story is credible. Against that, the Q2'26 print last night was mixed: revenue $176.1M beat (+14% YoY) but GAAP EPS $0.77 missed, sending shares -5.7% after hours. JP Morgan cut its target to $178 from $236 on July 29 and estimate revisions ahead of the print were negative — the sell-side had already been trimming expectations. Institutional ownership rose meaningfully (+6.8pp to ~78-79%) which is a positive positioning shift, but short float also climbed to 26.4% (+3.3pp) — informed hedged/short positioning is building into the multi-year capex ramp.
- July 2026 $1B+ DOE HALEU production contract (including options) transitions Piketon from demo to commercial-scale enrichment
- $560M Oak Ridge centrifuge plant expansion adds long-term enrichment capacity for LEU and HALEU
- New Oklo partnership (late July 2026) plugs Centrus into the advanced-reactor fuel supply chain
- $3.9B+ contracted backlog through 2040 provides multi-decade revenue visibility for LEU segment
- Q1'26 41.1% gross margin demonstrates the operating-leverage ceiling if throughput normalizes
- Q2'26 EPS miss ($0.77 vs consensus) + JPM target cut to $178 signals sell-side de-rating still in progress
- Forward P/E ~68x and EV/EBITDA ~73x leave zero cushion for another disappointment
- FCF burn accelerating: Q1'26 -$58.3M with capex ramping — dilution risk is real despite $1.87B cash
- Short float 26.4% (+3.3pp in 45d) reflects growing informed positioning against the rally
- Revenue lumpiness (Q3'25 $74.9M vs Q2'25 $154.5M) makes any single quarter unreliable as a re-rating anchor
- DOE $1B contract value depends on option exercises not guaranteed — political/budget risk to headline figure
- Advanced-reactor customer demand (Oklo, NuScale) remains pre-revenue and deployment timelines routinely slip
- Countertrend rally into structural resistance $190-210; prior rejections have led to 20%+ drawdowns
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord